WO2009034028A3 - Neue verbindungen - Google Patents

Neue verbindungen Download PDF

Info

Publication number
WO2009034028A3
WO2009034028A3 PCT/EP2008/061770 EP2008061770W WO2009034028A3 WO 2009034028 A3 WO2009034028 A3 WO 2009034028A3 EP 2008061770 W EP2008061770 W EP 2008061770W WO 2009034028 A3 WO2009034028 A3 WO 2009034028A3
Authority
WO
WIPO (PCT)
Prior art keywords
salts
novel compounds
hydrates
relates
compounds
Prior art date
Application number
PCT/EP2008/061770
Other languages
English (en)
French (fr)
Other versions
WO2009034028A2 (de
Inventor
Dirk Gottschling
Georg Dahmann
Henri Doods
Alexander Dreyer
Stephan Georg Mueller
Klaus Rudolf
Gerhard Schaenzle
Dirk Stenkamp
Original Assignee
Boehringer Ingelheim Int
Dirk Gottschling
Georg Dahmann
Henri Doods
Alexander Dreyer
Stephan Georg Mueller
Klaus Rudolf
Gerhard Schaenzle
Dirk Stenkamp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int, Dirk Gottschling, Georg Dahmann, Henri Doods, Alexander Dreyer, Stephan Georg Mueller, Klaus Rudolf, Gerhard Schaenzle, Dirk Stenkamp filed Critical Boehringer Ingelheim Int
Publication of WO2009034028A2 publication Critical patent/WO2009034028A2/de
Publication of WO2009034028A3 publication Critical patent/WO2009034028A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Gegenstand der vorliegenden Erfindung sind neue CGRP-Antagonisten der allgemeinen Formel (I) in der A, X, R1, R2 und R3 wie nachstehend erwähnt definiert sind, deren Tautomere, deren Isomere, deren Diastereomere, deren Enantiomere, deren Hydrate, deren Gemische und deren Salze sowie die Hydrate der Salze, insbesondere deren physiologisch verträgliche Salze mit anorganischen oder organischen Säuren oder Basen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung.
PCT/EP2008/061770 2007-09-07 2008-09-05 Neue verbindungen WO2009034028A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07115901 2007-09-07
EP07115901.6 2007-09-07

Publications (2)

Publication Number Publication Date
WO2009034028A2 WO2009034028A2 (de) 2009-03-19
WO2009034028A3 true WO2009034028A3 (de) 2009-05-22

Family

ID=39223011

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/061770 WO2009034028A2 (de) 2007-09-07 2008-09-05 Neue verbindungen

Country Status (1)

Country Link
WO (1) WO2009034028A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008239754A1 (en) * 2007-04-11 2008-10-23 Merck Sharp & Dohme Corp. CGRP receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups
GB201707938D0 (en) 2017-05-17 2017-06-28 Univ Sheffield Compounds
GB201818651D0 (en) * 2018-11-15 2019-01-02 Univ Sheffield Compounds

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031226A (en) * 1975-08-13 1977-06-21 Janssen Pharmaceutica N.V. N-[(1-piperidinyl)alkyl]arylcarboxamide derivatives
JP2001278886A (ja) * 2000-03-28 2001-10-10 Dai Ichi Seiyaku Co Ltd ベンゾオキサジン誘導体及びこれを含有する医薬
WO2005100360A1 (de) * 2004-04-15 2005-10-27 Boehringer Ingelheim International Gmbh Ausgewaehlte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031226A (en) * 1975-08-13 1977-06-21 Janssen Pharmaceutica N.V. N-[(1-piperidinyl)alkyl]arylcarboxamide derivatives
JP2001278886A (ja) * 2000-03-28 2001-10-10 Dai Ichi Seiyaku Co Ltd ベンゾオキサジン誘導体及びこれを含有する医薬
WO2005100360A1 (de) * 2004-04-15 2005-10-27 Boehringer Ingelheim International Gmbh Ausgewaehlte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 00, 2001 *

Also Published As

Publication number Publication date
WO2009034028A2 (de) 2009-03-19

Similar Documents

Publication Publication Date Title
WO2009065919A3 (de) Organische verbindungen
WO2009065920A3 (de) Verbindungen
WO2005103037A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
WO2009065922A3 (de) Organische verbindungen
TW200602338A (en) Selected CGRP antagonists, process for preparing them and their use as pharmaceutical compositions
WO2007036532A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
TW200603799A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
MY146623A (en) Substituted prolinamides, manufacturing, and the use thereof as medicaments
TW200738693A (en) Substituted biaryls, process for their manufacture and use thereof as medicaments
WO2009034029A3 (de) 1-substituierte 4 -heterocyclylpiperidine als cgrp antagonisten
WO2008116107A3 (en) Piperazine derivatives as glucokinase activators
WO2010014930A3 (en) Piperidine derivatives as jak3 inhibitors
WO2008005368A3 (en) Piperazines as p2x7 antagonists
MXPA05004188A (es) Antagonistas de cgrp elegidos, procedimiento para su preparacion, asi como su empleo como medicamentos.
TW200738692A (en) New substituted glycinamides, process for their manufacture and use thereof as medicaments
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
MX2010003849A (es) Antagonistas de cgrp.
WO2007020261A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
TW200800962A (en) Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
RS54413B1 (en) [4- (5-AMINOMETHYL-2-FLUORO-PHENYL) -PIPERIDIN-1-IL] - [7-FLUORO-1- (2-METHOXY-ETHYL) -4TRIFLUOROMETOXY-1H-INDOL-3-IL] METHANONE AS INHIBITOR MASTOCYT TRIPTASES
WO2008054956A3 (en) Kinase inhibitors
MX352548B (es) Compuestos disustituidos de tetrahidrofuranilo como antagonistas de receptor de bradiquinina b1.
WO2007048841A3 (de) Neue indol-haltige beta-agonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel
WO2009129401A8 (en) Kinase inhibitors
WO2009065921A3 (de) Organischeverbindungen

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08803739

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08803739

Country of ref document: EP

Kind code of ref document: A2